Posts Tagged ‘efficacy’
Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
Baxter International Inc. (NYSE:BAX), in conjunction with DynPort Vaccine Company LLC (DVC), a CSC Company (NYSE:CSC), presented Phase III study data measuring the clinical efficacy for PREFLUCEL, a trivalent seasonal influenza candidate vaccine. PREFLUCEL is made using Baxter’s Vero cell culture platform and does not contain an adjuvant or preservatives…
Vaccinating Children For Flu May Help Prevent Transmission, Protect Those Who Are Not Vaccinated
Immunizing children and adolescents with inactivated influenza vaccine resulted in reduced rates of influenza in their community compared to a similar community in which children did not receive the vaccine, suggesting that vaccinating children may help prevent transmission of the virus and offer protection for unimmunized community residents, according to a study in the March 10 issue of JAMA…
Pharmacy Swine Flu Trial Moves Into Phase II – Pharmaceutical Society Of Australia
The first phase of a swine flu vaccination program trial conducted in Tasmania by the Pharmaceutical Society of Australia and the Department of Health and Human Services has proved popular with the community. Phase II of the pandemic vaccination program will now be rolled out to allow pharmacy-based clinics to support other elements of the swine flu vaccination program…
Vaccinating Kids Against Flu Protects Whole Community, Canadian Study
A new study carried out in Hutterite communities in Canada revealed that giving kids and teenagers flu shots led to lower rates of flu in communities that followed such a strategy compared to similar communities that did not, suggesting that vaccinating children may prevent the virus from spreading and protects members of the community who are not vaccinated, produc…
Dog Flu: Canine Influenza (CIV) In Dogs
|
In this pet care video we learn about dog flu (Canine Influenza). Yes, just like people, dogs can get the flu. Canine influenza has emerged as a serious cause of canine infectious respiratory disease (CIRD) complex in recent years. Dr. Mike explains the signs, diagnoses and treatment for dog flu as well as a vaccine, Canine Influenza Vaccine, H3N8, for canine influenza that can aid in control of the disease.
|
From:VetVid
Views:
56 ![]() ![]() ![]() ![]() ![]() 3
ratings |
|
| Time:02:43 | More inPets & Animals |
Pandemic Flu, Like Seasonal H1N1, Shows Signs Of Resisting Tamiflu
If the behavior of the seasonal form of the H1N1 influenza virus is any indication, scientists say that chances are good that most strains of the pandemic H1N1 flu virus will become resistant to Tamiflu, the main drug stockpiled for use against it…
AmpVacs A Broadly Protective Synthetic Influenza A Vaccine
Sanquin Blood Supply Foundation, the Netherlands Cancer Institute, and the Netherlands Vaccine Institute announce the launch of their joint AmpVacs project aiming at the development of a broadly protective synthetic influenza A vaccine component that in combination with classical antibody-stimulating vaccines will induce protection against future influenza A threats…
Dry Winters Linked To Seasonal Outbreaks Of Influenza
The seasonal increase of influenza has long baffled scientists, but a new study published this week in PLoS Biology has found that seasonal changes of absolute humidity are the apparent underlying cause of these wintertime peaks. The study also found that the onset of outbreaks might be encouraged by anomalously dry weather conditions, at least in temperate regions…
Loyola Physician Discusses What Happened To The Flu
Normally, this is the peak period for the flu in the United States. But that just doesn’t seem to be the case this year. The number of states reporting widespread cases of the flu mysteriously plunged from 49 at the end of October to zero at the beginning of the January, according to the Centers for Disease Control and Prevention…
Project GreenVax Announced By Texas-Based Consortium
Leaders of the Texas Plant-Expressed Vaccine Consortium have announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation’s capability to produce vaccines for infectious diseases, including influenza…





